Pfizer

Pharmaceutical manufacturing Visit pfizer.com

Updated 2026-11-12 Data as of 2026-11-12

Share:

Based in New York, United States, Pfizer is a Pharmaceutical manufacturing company established in 1849 (NYSE: PFE).

Pfizer Inc. is a biopharmaceutical company with global headquarters at 66 Hudson Boulevard East in New York City. Cousins Charles Pfizer and Charles Erhart founded Charles Pfizer & Company in 1849 in a red brick building in Brooklyn, and the present company was incorporated in Delaware on June 2, 1942. Its common stock trades on the New York Stock Exchange under the ticker PFE. Pfizer discovers, develops, manufactures and sells medicines and vaccines across oncology, internal medicine, inflammation and immunology, and vaccines, and manages its commercial operations through three operating segments: Biopharma, PC1 and Pfizer Ignite. It reported revenues of 62.6 billion dollars for 2025 and employed approximately 75,000 people worldwide at year end. Pfizer Global Supply runs 36 manufacturing plants, including in Belgium, Germany, India, Ireland, Italy, Japan, Singapore and the United States. Albert Bourla has been chief executive officer since January 2019 and chairman since January 2020. The company acquired Seagen in December 2023 and Metsera in November 2025. It employs Approximately 75,000 people worldwide (Form 10-K, December 31, 2025) people, led by Albert Bourla (Chairman and Chief Executive Officer), across roughly 75,000 tracked profiles. Firmographics, leadership, tech stack and similar companies are detailed below, as of 2026-11-12.

EmployeesApproximately 75,000 people worldwide (Form 10-K, December 31, 2025)As of 2026-11-12
Founded1849177 years in business
HeadquartersNew YorkUnited States
Revenue$62.6BFiscal year 2025
Leaders listed10Led by Albert Bourla
Technologies52Detected on its website
Oncology medicines, including antibody-drug conjugates gained with SeagenVaccines, including the Prevnar pneumococcal family and Comirnaty with BioNTechInternal medicine, with an obesity and cardiometabolic program built on MetseraInflammation and immunologyBiosimilars and sterile injectablesPC1 contract development and manufacturing, and specialty active pharmaceutical ingredientsPfizer Ignite research and development services for biotech companies

Get this data with Derrick Enrich Companies

Pfizer tech stack

52 technologies detected on pfizer.com, as of 2026-11-12.

Technologies by category
Technologies by category
NameTechnologiesShare
JavaScript library35.8%
Programming language35.8%
Advertising23.8%
Analytics23.8%
Bot protection23.8%
CDN23.8%
Real user monitoring23.8%
Tag management23.8%
TechnologyCategory
DDrupal CMS
HHugo Static site generator
QQ4 Investor relations platform
AAdobe Analytics Analytics
AAdobe Audience Manager Data management platform
AAdobe Experience Platform Identity Service Customer data platform
AAdobe Experience Platform Launch Tag management
GGoogle Analytics Analytics
GGoogle Tag Manager Tag management
MMixpanel Product analytics
SSnowplow Analytics Behavioral data platform
DDecibel Digital experience analytics
MMedallia Customer experience management
CCloudflare Browser Insights Real user monitoring
AAmazon CloudWatch RUM Real user monitoring
OOracle Dynamic Monitoring Service Application monitoring
FFacebook Pixel Advertising
LLinkedin Ads Advertising
AAmazon Web Services Cloud hosting
AAmazon ALB Load balancer
AAmazon CloudFront CDN
AAmazon S3 Object storage
AAmazon SES Email delivery
CCloudflare CDN
CCloudflare Bot Management Bot protection
VVarnish HTTP cache
AApache HTTP Server Web server
IIIS Web server
WWindows Server Operating system
OOracle WebLogic Server Application server
MMicrosoft ASP.NET Web framework
JJava Programming language
PPHP Programming language
TTypeScript Programming language
AAngular JavaScript framework
PPreact JavaScript library
llit-element Web components library
jjQuery JavaScript library
BBootstrap UI framework
ZZURB Foundation UI framework
SSwiper JavaScript library
VVideoJS Video player
YYouTube Video hosting
LLottieFiles Animation
TTypekit Web fonts
FFont Awesome Icon library
OOneTrust Consent management
rreCAPTCHA Bot protection
SServiceNow IT service management
DDocuSign E-signature
AAddToAny Social sharing
AApple iCloud Mail Email

Get this data with Derrick Website Technologies

Pfizer news & media

  • P
    Pfizer and Blackstone Life Sciences Announce Strategic Funding Agreement for Obesity Program

    Blackstone will be eligible for milestone payments tied to U.S. approval of monthly injectable berobenatide and to commercial sales milestones.

    Pfizer · November 2026
  • P
    Pfizer Appoints Cecile Guegan as Chief Financial Officer

    The board appointed her unanimously; she brings more than 25 years of pharmaceutical finance experience.

    Pfizer · November 2026
  • P
    Pfizer Reports Strong Third-Quarter 2026 Results And Raises 2026 Guidance

    Third-quarter revenues came to 16.6 billion dollars, after 15.0 billion dollars in the second quarter and 14.5 billion dollars in the first.

    Pfizer · November 2026
  • P
    Pfizer's ELREXFIO Outperforms Standard Regimens and Meets Primary Endpoint in Phase 3 Study in Relapsed or Refractory Multiple Myeloma

    More than 75% of patients on ELREXFIO had not progressed or died at the time of the analysis, with an estimated 68% progression-free survival at 18 months.

    Pfizer · October 2026
  • P
    Pfizer's TALZENNA Plus XTANDI FDA-Approved for an Earlier Metastatic Prostate Cancer Treatment Setting

    TALAPRO-3 showed an estimated 52% reduction in the risk of radiographic progression or death.

    Pfizer · October 2026
  • P
    Pfizer's 25-Valent Pediatric Pneumococcal Conjugate Vaccine Candidate Shows Robust Phase 2 Data at IDWeek 2026

    A four-dose series produced immune responses against all 25 serotypes, with safety comparable to PREVNAR 20.

    Pfizer · October 2026
  • P
    Pfizer's TUKYSA Regimen Receives FDA Approval as Front-Line Maintenance Treatment for HER2+ Metastatic Breast Cancer

    The regimen showed more than 50% improvement in median progression-free survival in HER2CLIMB-05.

    Pfizer · October 2026
  • P
    Pfizer Declares Fourth-Quarter 2026 Dividend

    The 0.43 dollar dividend goes to holders of record at the close of business on November 6, 2026.

    Pfizer · October 2026
  • P
    Pfizer's LITFULO Significantly Improved Facial and Total Body Repigmentation in Patients with Nonsegmental Vitiligo

    Results from the TRANQUILLO and TRANQUILLO 2 Phase 3 trials were presented at the EADV congress in Vienna.

    Pfizer · October 2026
  • P
    Pfizer's Tilrekimig Shows Significant Skin Clearance in Phase 2 Atopic Dermatitis Study

    The trispecific antibody binds IL-4, IL-13 and TSLP and has a half-life of about 37 days, which could support monthly dosing.

    Pfizer · October 2026
  • P
    Pfizer and BioNTech Receive U.S. FDA Approval for XFG-adapted COVID-19 Vaccine

    The approval covers adults 65 and older and people aged 5 through 64 with at least one underlying high-risk condition.

    Pfizer · August 2026
  • P
    Pfizer and Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated by European Medicines Agency

    The 6-valent OspA-based candidate was well tolerated in the VALOR trial, in people aged five and older.

    Pfizer · August 2026
  • P
    Pfizer Reports Second-Quarter Results And Raises Midpoint of 2026 Revenue Guidance

    Second-quarter revenues were 15.0 billion dollars, for 29.5 billion dollars over the first half of 2026.

    Pfizer · August 2026
  • P
    U.S. FDA Approves PADCEV plus Keytruda as Neoadjuvant and Adjuvant Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

    The approval, with Astellas, rests on Phase 3 EV-304 data showing a 35% reduction in the risk of death versus standard of care.

    Pfizer · July 2026
  • P
    Pfizer Announces Chief Financial Officer Transition

    Dave Denton was to leave on August 15, with Cecile Guegan named interim chief financial officer from August 16.

    Pfizer · June 2026

Get this data with Derrick Google News Scraper

Pfizer recent signals

  • Signed a co-funding agreement under which funds managed by Blackstone Life Sciences will pay up to 1.5 billion dollars of development costs through 2028 for berobenatide, an investigational monthly GLP-1 receptor agonist for chronic weight managementNovember 2026
  • The board appointed Cecile Guegan chief financial officer and executive vice president, effective November 1, 2026; she had been interim chief financial officer since August 16, 2026November 2026
  • Reported third-quarter 2026 revenues of 16.6 billion dollars, bringing revenues for the first nine months of 2026 to 46.1 billion dollars, and raised its 2026 guidanceNovember 2026
  • The FDA expanded approval of TALZENNA plus XTANDI to an earlier metastatic prostate cancer setting for men with HRR gene mutations, based on Phase 3 TALAPRO-3 dataOctober 2026
  • ELREXFIO met its primary endpoint of progression-free survival in the Phase 3 MagnetisMM-32 study in relapsed or refractory multiple myelomaOctober 2026
  • The FDA approved TUKYSA with trastuzumab and pertuzumab as a chemotherapy-free front-line maintenance treatment for HER2-positive metastatic breast cancerOctober 2026
  • Declared a fourth-quarter 2026 dividend of 0.43 dollars per share, payable December 7, 2026, the 352nd consecutive quarterly dividend paid by the companyOctober 2026
  • The FDA approved the 2026-2027 COVID-19 vaccine formula from Pfizer and BioNTech targeting the XFG variant, with shipping starting immediatelyAugust 2026
  • The European Medicines Agency validated the marketing authorization application for the Lyme disease vaccine candidate developed with Valneva, based on efficacy of more than 70% in the Phase 3 VALOR trialAugust 2026
  • Chief financial officer Dave Denton left the company on August 15, 2026 for a role in consumer goodsAugust 2026
  • Completed the acquisition of Metsera, the base of its obesity and cardiometabolic pipelineNovember 2025

Get this data with Derrick Signal

Pfizer workforce (~75,000 tracked)

Distribution estimated from roughly 75,000 tracked public profiles, as of 2026-11-12. Use it for proportions, not exact headcounts.

By functionEstimated profiles
By function
NameProfiles
Pfizer Global Supply (manufacturing, quality and supply chain)31,000
Commercial (U.S. and international)22,000
Research, development and medical12,000
Digital and technology3,500
Finance, legal, people experience and other corporate functions6,500
By locationEstimated profiles
United States: 30,000 (40%)Europe: 22,000 (29%)Asia Pacific: 14,000 (19%)Latin America: 5,000 (6.7%)Africa and Middle East: 4,000 (5.3%)
  • United States30,00040%
  • Europe22,00029%
  • Asia Pacific14,00019%
  • Latin America5,0006.7%
  • Africa and Middle East4,0005.3%
By location
NameProfilesShare
United States30,00040%
Europe22,00029%
Asia Pacific14,00019%
Latin America5,0006.7%
Africa and Middle East4,0005.3%
By management levelEstimated profiles
By management level
NameProfilesShare
Executive Leadership Team10<0.1%
Senior vice presidents and vice presidents9001.2%
Directors and senior managers9,00012%
Managers and team leads16,00021%
Individual contributors49,09065%

Get this data with Derrick Find a company's people

Pfizer leadership

10 current leaders are tracked, led by Albert Bourla. Contact details stay locked on this page and are revealed in the app.

LeaderEmailProfile
ABAlbert BourlaAlbert BourlaChairman and Chief Executive Officer ••••@pfizer.com
CGCecile GueganChief Financial Officer and Executive Vice President ••••@pfizer.com
CBChris BoshoffChief Scientific Officer and President, Research & Development ••••@pfizer.com
AMAamir MalikChief U.S. Commercial Officer ••••@pfizer.com
ADAlexandre de GermayChief International Commercial Officer ••••@pfizer.com
DLDoug LanklerChief Legal Officer ••••@pfizer.com
MMMike McDermottChief Global Supply and Quality Officer ••••@pfizer.com
PSPayal SahniChief People Experience Officer ••••@pfizer.com
DHDennis HancockChief Information Officer ••••@pfizer.com
LHLindsay HavernHead of Strategy, Executive Operations, Counsel to the CEO ••••@pfizer.com

Get this data with Derrick Find a company's people

Find verified emails for the 10 leaders listed here and anyone else at Pfizer in the Derrick web app (5 credits per email found), or track Pfizer with Signal to be alerted when its leaders change jobs, it raises funds or starts hiring (Standard plan and up).

Companies similar to Pfizer

CompanyRevenueEmployeesHQFounded
MMerck & Co. United States
JJohnson & Johnson United States
AAbbVie United States
BBristol Myers Squibb United States
EEli Lilly United States
NNovartis Switzerland
RRoche Switzerland
AAstraZeneca United Kingdom

Get this data with Derrick Find Similar Companies

Pfizer org chart

ABAlbert BourlaChairman and Chief Executive Officer

Get this data with Derrick Find a company's people

Pfizer financials

Revenue$62.6B
Fiscal year2025
SIC2834
TickerNYSE: PFE
FAQ

Pfizer FAQ

What does Pfizer do?

Pfizer Inc. is a biopharmaceutical company with global headquarters at 66 Hudson Boulevard East in New York City. Cousins Charles Pfizer and Charles Erhart founded Charles Pfizer & Company in 1849 in a red brick building in Brooklyn, and the present company was incorporated in Delaware on June 2, 1942. Its common stock trades on the New York Stock Exchange under the ticker PFE. Pfizer discovers, develops, manufactures and sells medicines and vaccines across oncology, internal medicine, inflammation and immunology, and vaccines, and manages its commercial operations through three operating segments: Biopharma, PC1 and Pfizer Ignite. It reported revenues of 62.6 billion dollars for 2025 and employed approximately 75,000 people worldwide at year end. Pfizer Global Supply runs 36 manufacturing plants, including in Belgium, Germany, India, Ireland, Italy, Japan, Singapore and the United States. Albert Bourla has been chief executive officer since January 2019 and chairman since January 2020. The company acquired Seagen in December 2023 and Metsera in November 2025.

What is Pfizer's stock symbol?

Pfizer's stock symbol is PFE, listed on NYSE (as of 2026-11-12).

What is Pfizer's official website?

Pfizer's official website is pfizer.com.

What is Pfizer's revenue?

Pfizer's revenue is $62.6B (FY2025), as of 2026-11-12.

Where is Pfizer headquartered?

Pfizer's headquarters is at 66 Hudson Boulevard East, New York, New York 10001, United States (as of 2026-11-12).

When was Pfizer founded?

Pfizer was founded in 1849.

How many employees does Pfizer have?

Pfizer has Approximately 75,000 people worldwide (Form 10-K, December 31, 2025) employees (as of 2026-11-12).

What industry is Pfizer in?

Pfizer operates in the Pharmaceutical manufacturing industry.

What is Pfizer's SIC code?

Pfizer's SIC code is 2834.

Who is the CEO of Pfizer?

Albert Bourla is the Chairman and Chief Executive Officer of Pfizer (as of 2026-11-12).

Who is the CFO of Pfizer?

Cecile Guegan is the Chief Financial Officer and Executive Vice President of Pfizer (as of 2026-11-12).

Who are Pfizer's competitors?

Companies similar to Pfizer include Merck & Co., Johnson & Johnson, AbbVie, Bristol Myers Squibb (as of 2026-11-12).

What technology does Pfizer use?

Pfizer's tracked tech stack includes Drupal, Hugo, Q4, Adobe Analytics, Adobe Audience Manager, Adobe Experience Platform Identity Service (as of 2026-11-12).

What is Pfizer's email format?

Pfizer generally uses the first.last@pfizer.com email format. Find and verify a specific person's address with Derrick.

What are Pfizer's social media links?

Pfizer is on LinkedIn at https://www.linkedin.com/company/pfizer.

Is Pfizer a public company?

Yes. Pfizer is publicly traded as NYSE: PFE.